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Abstract
Influenza A viral infections have been identified as the etiologic agents for historic pandemics, and contribute to the annual
mortality associated with acute viral pneumonia. While both innate and acquired immunity are important in combating
influenza virus infection, the mechanism connecting these arms of the immune system remains unknown. Recent data have
indicated that the Notch system is an important bridge between antigen-presenting cells (APCs) and T cell communication
circuits and plays a central role in driving the immune system to overcome disease. In the present study, we examine the
role of Notch signaling during influenza H1N1 virus infection, focusing on APCs. We demonstrate here that macrophages,
but not dendritic cells (DCs), increased Notch ligand Delta-like 1 (Dll1) expression following influenza virus challenge. Dll1
expression on macrophages was dependent on retinoic acid-inducible gene-I (RIG-I) induced type-I IFN pathway, and not on
the TLR3-TRIF pathway. We also found that IFNa-Receptor knockout mice failed to induce Dll1 expression on lung
macrophages and had enhanced mortality during influenza virus infection. Our results further showed that specific
neutralization of Dll1 during influenza virus challenge induced higher mortality, impaired viral clearance, and decreased
levels of IFN-c. In addition, we blocked Notch signaling by using c-secretase inhibitor (GSI), a Notch signaling inhibitor.
Intranasal administration of GSI during influenza infection also led to higher mortality, and higher virus load with excessive
inflammation and an impaired production of IFN-c in lungs. Moreover, Dll1 expression on macrophages specifically
regulates IFN-c levels from CD4
+and CD8
+T cells, which are important for anti-viral immunity. Together, the results of this
study show that Dll1 positively influences the development of anti-viral immunity, and may provide mechanistic approaches
for modifying and controlling the immune response against influenza H1N1 virus infection.
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Introduction
Influenza virus type A causes acute respiratory infections that
are highly contagious and cause significant morbidity and
mortality in humans and animals [1,2]. In 2009, the influenza
pandemic caused by the current H1N1 virus affected all the
continents of the world [3]. In the United States alone, the 2009
H1N1 influenza virus affected 57 million Americans, with more
than 11,000 deaths (CDC report; http://www.cdc.gov/h1n1flu/
estimates_2009_h1n1.htm). Although vaccines and other antiviral
approaches to control influenza recently have been developed, the
disease is by no means under control since these treatments are not
available worldwide and their efficacy is less than optimal [1,4].
Thus, a better understanding of the molecular mechanisms of
pathogenesis and of the host immune response to influenza virus
infection is required for the prevention and treatment of influenza.
A viral infection is initially sensed by the host innate system,
triggering a rapid antiviral response that involves the release of
proinflammatory cytokines, and eventually leads to the activation
of the adaptive immune response [5]. The first line of defense is
initiated when cellular pathogen recognition receptors (PRRs)
recognize pathogen-associated molecular patterns (PAMPs) in-
cluding influenza virus [6,7]. In many PAMPs, RNA virus is
recognized not only by PRR Toll-like receptor 3 (TLR3) but also
by RIG-I and melanoma-differentiation-associated gene 5
(MDA5) [8]. During the life cycle of influenza virus, these proteins
in turn activate the TBK1 and IKKi kinases, which phosphorylate
interferon-regulatory factor-3 (IRF-3) and IRF-7, transcription
factors essential for the expression of type-I IFNs [9].
The type-I IFN (IFN-a/b) cytokines are vital to the innate
immune response and control the expression of.100 gene
products, several of which directly reduce viral replication and
spreading by conferring the so-called ‘‘antiviral state’’ [10]. IFN-
ab activates these downstream processes by initially engaging the
IFN-a receptor (IFNaR) and activating the JAK-STAT pathway
[11]. This pathway induces a number of early-response, IFN-
stimulated genes (ISGs) including type II IFN (IFN-c) [12].
Furthermore, IFN-ab also activates NFkB, which amplifies the
IFN response via a positive-feedback loop. This feedback is
important for the recruitment of specialized immune cells to the
site of injury or viral infection [6]. IFN-ab is initially produced by
leukocytes and fibroblasts, leading to the recruitment of T and NK
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key antiviral factors, most notably PKR (RNA-activated protein
kinase), a serine/threonine kinase induced by both IFN type I and
type II stimulation [12,13]. Thus, IFN-ab and IFN-c affect the
activities of macrophages, T cells, dendritic cells (DCs), and NK
cells by enhancing antigen presentation, cell trafficking, and cell
differentiation profiles, which ultimately enhances antiviral effector
functions [13].
In the last decade, it has been demonstrated that Notch
signaling pathways contribute to both the hematopoietic and
immune systems including a role in the development of embryonic
hematopoietic stem cells and a role in multiple lineage decisions of
developing lymphoid and myeloid cells [14]. There are 5
mammalian ligands (Delta-like [Dll]1, Dll3, Dll4, Jagged-1, and
Jagged-2), each of which can activate any of the 4 Notch receptors
(Notch1, -2, -3, -4) [15]. Notch signaling during lymphoid
development has been extensively studied, and its essential role
in specifying cell fate at many stages during T-cell development is
well characterized [14]. Moreover, recent data have indicated that
the Notch signaling pathway is an important modulator of Tcell-
mediated immune responses [15]. For example, Notch signaling is
associated with the differentiation of naive CD8
+Tcells to
cytotoxic T lymphocytes (CTLs), and cytotoxic CD8
+T are
recruited to kill virus-infected cells by the production of IFN-c
[14]. Another function that was assigned to Notch is the regulation
of T helper (Th) cell differentiation. The importance of Notch
activation has been supported using GSI, which is a pharmaco-
logic inhibitor of Notch signaling pathways, to block the induction
of Th1-type responses [14]. Upon recognition of pathogens and
presentation of antigen via MHC class II proteins by antigen-
presenting cells (APCs) such as macrophages and DCs, CD4
+Th
cells become activated, drive adaptive immunity and induce
specific responses to invading microbes [14]. For instance, Th1 cell
induction by forced Dll expression on the surface of APCs was
shown to induce Th1 cell differentiation, and Dll ligands were
thought to inhibit Th2 cell differentiation by interfering with IL-4
receptor signaling [14]. On the other hand, expression of Jagged
ligands, but not Dll, on the surface of APCs was shown to induce
Th2 cell differentiation [14]. Further, we have demonstrated that
Dll4 induction on DCs can specifically promote the generation of
Th17 cells [16].
In the present study, we examine the role of Notch signaling
during influenza H1N1 virus infection, focusing on APCs because
of their central role in driving the immune system to overcome
disease. We demonstrate that macrophages, but not DCs,
increased Notch ligand Dll1 expression following influenza virus
stimulation. Dll1 expression on bone marrow-derived macrophag-
es (BMDMs) was dependent on RIG-I induced type-I IFN
pathway, and not on the TLR3-TRIF pathway. We also found
that IFNaR
2/2 mice failed to induce Dll1 expression on lung
macrophages and had enhanced mortality during influenza virus
infection. Our results further showed that specific neutralization of
Dll1 during treatment with a Notch signaling inhibitor during
influenza virus challenge induced higher mortality, impaired viral
clearance, and decreased levels of IFN-c. Together, the results of
this study show that Dll1 positively influences the development of
anti-viral immunity, and may provide mechanistic approaches for
modifying and controlling the immune response against influenza
H1N1 virus infection.
Results
Macrophages, but not DCs, exhibited increased
expression level of Dll1
Since we previously demonstrated that Dll4 was upregulated on
BM-derived DCs (BMDCs) following exposure to certain bacterial
antigens including CpG (TLR9 ligand) and BCG [16], we first
assessed the gene expression profile of Notch ligands on APCs
following influenza virus stimulation. During H1N1 stimulation no
Notch ligands were induced on BMDCs (Fig. 1A), while Dll1
mRNA levels were increased in BMDMs (Fig. 1B). Dll3
expression was below detection levels of our assay. In agreement
with the data from BMDMs, H1N1 induced the expression of Dll1
on RAW264.7 cells, a mouse leukemic monocyte macrophage cell
line (Fig. S1). We next examined protein levels of Notch ligands
following treatment with various TLR ligands. No TLR ligands
induced expression of Dll1 on BMDCs (CD11b
+CD11c
+)
(Fig. 1C). Though H1N1 failed to induce Dll4 on BMDCs,
Dll4 expression was induced on BMDCs following LPS (TLR4
ligand) and CpG (TLR9 ligand) treatment, indicating that Dll4
induction on DCs is dependent on MyD88 signaling pathway as
previously described [17]. When we examined BMDMs
(CD11b
+F4/80
+), we found that Dll1 expression was induced
during H1N1 stimulation as well as by PolyI:C (TLR3 ligand) and
LPS stimulation, while no Dll4 expression was induced following
any of these treatments (Fig. 1D). In addition, ELISA analysis
showed that H1N1 stimulation as well as PolyI:C and LPS
stimulation, but not CpG stimulation, induced production of type-
I IFNs by BMDMs (Fig. S2). The increased gene expression of
both Dll1 and IFN-b were also associated with an increase of the
viral load of H1N1 (Fig. S3).
Dll1 expression on BMDMs is dependent upon type-I IFN
To further investigate the induction mechanism for Dll1, we
examined Dll1 expression using WT, TRIF
2/2, MyD88
2/2, and
IFNaR
2/2 mice. As shown in Fig. 2A, the mRNA expression
levels of Dll1 following H1N1 stimulation in BMDMs from
IFNaR
2/2 mice was completely abrogated, while Dll1 expression
in TRIF
2/2 and MyD88
2/2 mice was comparable to its
expression in WT mice. Further, LPS stimulation of BMDMs
from TRIF
2/2 mice did not increase expression of Dll1 when
compared to WT mice. Moreover, BMDMs from IFNaR
2/2
Author Summary
Influenza viruses cause annual epidemics and occasional
pandemics that have claimed the lives of millions. Both
innate and acquired immunity are essential for protection
against influenza virus, and Notch and Notch ligands
provide a key bridge between innate and acquired
immunity. However, the role of Notch system during
influenza virus infection is unknown. Here, we show that
Notch ligand Delta-like 1 (Dll1) expression was up-
regulated in influenza virus H1N1 challenged macrophag-
es, and was dependent on both retinoic-acid–inducible
protein I (RIG-I) and IFNa receptor (IFNaR)-mediated
pathways. IFNaR-deficient mice challenged with influenza
virus in vivo also display a profoundly impaired Dll1
expression with increased mortality and abrogated IFN-c
production. Treatment of WT mice during influenza
infection, with either neutralizing antibodies specific for
Dll1 or a c-secretase inhibitor (GSI), which blocks Notch
signaling, resulted in increased mortality, impaired viral
clearance, and lower IFN-c production. In addition, Dll1
specifically regulated IFN-c production from both CD4
+and
CD8
+T cells in vitro. Together, these results suggest that
Notch signaling through macrophage-dependent Dll1 is
critical in providing an anti-viral response during influenza
infection by linking innate and acquired immunity.
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stimulation condition we examined (Fig. 2A). Additionally, when
BMDMs were pretreated with anti-IFN-b Ab before treatment
with H1N1 and PolyI:C, the expression of Dll1 was significantly
decreased (Fig. 2B). Flow cytometry data confirmed that Dll1
protein was not induced in BMDMs from IFNaR
2/2 mice
following H1N1 stimulation (Fig. 2C). These results were also
supported by confocal immunofluorescent analysis, which indi-
cated Dll1-positive expression (red) on F4/80-positive macrophag-
es (green) following influenza virus treatment in WT mice;
Figure 1. BMDMs, but not BMDCs, exhibit increased expression of Dll1. BM-derived DCs (BMDCs) (A) and BMDMs (MO /)(B) were stimulated
with H1N1 (MOI=10) for 6 hours, then quantitative real-time PCR was performed and the expression levels of Notch ligands were evaluated. BMDC
(CD11b
+CD11c
+)( C) and BMDM (CD11b
+F4/80
+)( D) were stimulated with PolyI:C (10 mg/ml), LPS (1 mg/ml), CpG (1 mM), or H1N1 (MOI=10) for
24 hours, then flow cytometry was performed as indicated in MATERIALS and METHODS. *P,0.05, **P,0.01 compared with PBS-treated cells. Data
shown indicate mean6SEM and are from a representative experiment of 3 independent experiments. Each time point represents at least 4 mice per
group. N.D.=No Detection, MFI=Mean Fluorescence Intensity.
doi:10.1371/journal.ppat.1002341.g001
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PLoS Pathogens | www.plospathogens.org 3 November 2011 | Volume 7 | Issue 11 | e1002341Figure 2. Dll1 expression expression is dependent upon type-I IFN. (A) Gene expression of Dll1 on BMDMs from WT, TRIF
2/2, MyD88
2/2,o r
IFNaR
2/2 mice following stimulation with PolyI:C (10 mg/ml), LPS (1 mg/ml), CpG (1mM), H1N1 (MOI=10), recombinant (r) IFN-a (20 Units), or rIFN-b
(20 Units) for 6 hours. *P,0.05, **P,0.01 compared with WT mice. (B) The gene expression level of Dll1 on BMDMs pretreated with anti-mouse IFN-b
Ab (2 mg/ml). *P,0.05, **P,0.01 compared with control (cont) Ab. (C) The level of Dll1 on BMDMs (CD11b
+F4/80
+) following stimulation with H1N1
(MOI=10) for 24 hours determined by flow cytometry. **P,0.01 compared with PBS-treated BMDMs. (D) Confocal immunofluorescent examination
of BMDMs stimulated with H1N1 (MOI=10) between WT and IFNaR
2/2 mice. F4/80: green, Dll1: red, DAPI: blue. Original magnification, 6400. Data
shown are mean 6 SEM and are a representative experiment of 3 independent experiments. Each point represents at least 3 mice per group.
doi:10.1371/journal.ppat.1002341.g002
The Role of Dll1 in Influenza Virus Infection
PLoS Pathogens | www.plospathogens.org 4 November 2011 | Volume 7 | Issue 11 | e1002341however, in IFNaR
2/2 mice, F4/80-positive macrophages (green)
were Dll1-negative (red) following H1N1 stimulation (Fig. 2D).
RIG-I like pathway and IFNaR-JAK/STAT pathway are
involved in Dll1 induction
RNA virus can trigger the TLR3-TRIF signaling pathway and/
or the RIG-I like pathway, each of which induces type-I IFN. To
determine whether these pathways also regulate Dll1 Notch ligand
expression, we next examined type-I IFN production and Dll1
gene expression levels during H1N1 stimulation in TRIF
2/2 mice
or by knocking down the RIG-I gene. IFN-a protein levels were
significantly lower and IFN-b protein was not detectable in RIG-I
siRNA-treated BMDMs compared with control siRNA-treated
BMDMs (Fig. 3 A and B). In contrast, levels of type 1 IFN
expression were unchanged when BMDMs from TRIF
2/2 mice
were compared to BMDMs from control mice (Fig. 3 A and B).
Similarly, the gene expression level of Dll1 was significantly lower
in RIG-I siRNA-treated macrophages when compared with
control siRNA-treated macrophages, whereas there was no
significant difference in Dll1 gene expression between BMDMs
from WT and TRIF
2/2 mice (Fig. 3C). The above studies
(Fig. 2) suggested that signaling through IFNaR is critical for Dll1
induction. Thus, we next examined the contribution of the JAK/
STAT pathway, which is downstream to IFNaR activation, on
Dll1 expression. Following PolyI:C, LPS, H1N1 or rIFN-b
stimulation, both STAT1 and STAT2 were phosphorylated and
Dll1 was detected in BMDMs from WT mice (Fig. 3D). However,
in BMDMs from IFNaR-deficient mice no STAT1/2 phosphor-
ylation and no Notch ligand Dll1 expression were seen. We also
demonstrated that BMDMs from STAT1
2/2 mice and BMDMs
from WT mice treated with JAK-I inhibitor failed to induce the
expression of Dll1 following stimulation with PolyI:C, H1N1 or
rIFN-b (Fig. 3 E and F). In addition, knocking down the STAT2
gene led to significantly lower expression of Dll1 (data not shown).
Together these results suggest that phosphorylation of STAT1 and
STAT2 are critical for Dll1 expression as is type-I IFN signaling
through IFNaR. Thus, H1N1 infection leads to the production of
type-I IFN via the RIG-I pathway in BMDMs. Type-I IFNs in
turn bind to IFNaR in an autocrine loop and activates the JAK/
STAT pathway that results in the transcription of Dll1.
IFNaR
2/2 mice are susceptible to influenza virus
infection with impaired induction of Dll1
Because we showed that Notch ligand Dll1 was critically
regulated by IFNaR in vitro, we next examined whether
IFNaR
2/2 mice infected with influenza virus failed to upre-
gulate Dll1. First, we monitored the survival of WT, IFNaR
2/2,
TRIF
2/2, and MyD88
2/2 mice following H1N1 infection up to
Day 20. We confirmed that the absence of IFNaR led to increased
mortality after viral challenge when compared to WT mice
(Fig. 4A). However, mice deficient for TRIF or MyD88 were not
significantly different from WT mice regarding mortality (Fig. 4A).
These findings were confirmed in lung histology studies 8 days post
infection, that showed a significant increase in lung inflammation in
IFNaR
2/2 mice, as compared to the WT, TRIF
2/2,a n d
MyD88
2/2 mice (Fig. 4B). In agreement with our in vitro BMDM
data, we found that Dll1 mRNA levels were increased in whole
lungs from WT mice over the study period, while the expression of
Dll1inwholelungsfromIFNaR
2/2micewassignificantlyloweron
both Day4andDay8afterviralchallenge(Fig.4C).Incontrast,no
significant difference was observed in expression of Dll4, Jagged1,
and Jagged2 in lungs from WT and IFNaR
2/2 mice (Fig. 4C).
Dll3 expression was below detection levels of our assay (data not
shown). In addition, flow cytometry demonstrated that Dll1
expression on lung macrophages (CD11b
+F4/80
+)w a ss i g n i f i -
cantly lower in IFNaR
2/2 mice when compared with WT mice
(Fig. 4D). These results were also confirmed by confocal
microscopy, which showed impaired detection of Dll1 (red) on
F4/80
+ macrophages (green) in IFNaR
2/2 mice during H1N1
infection (Fig. 4E).
Macrophages play an essential role during influenza virus
infection
To directly examine the importance of macrophages, we used
liposome- Dichloromethylenediphosphonic acid (DMDP) to de-
plete macrophages [18]. Intranasal administration of liposome-
DMDP during influenza infection led to higher mortality (Fig. 5A)
with greater virus load of 50% tissue culture infective dose
(TCID50) at both day 2 and day 7 post-infection (Fig. 5B). The
gene expressions of influenza H1N1 viral specific mRNA for
matrix protein (M1) and nonstructural protein (NS) were also
significantly higher in liposome-DMDP-treated mice (Fig. 5 C
and D). Cellular appearance of bronchoalveolar lavage (BAL)
cells demonstrated decreased number of macrophages and
increased number of neutrophils (Fig. 5 E and F). In addition,
most of the remaining macrophages in BAL cells from liposome-
DMDP-treated mice that were counted in Fig. 5F had the
appearance of dead cells. Moreover, the expression of Dll1 from
whole lungs was significantly lower in liposome-DMDP-treated
mice (Fig. 5G). We also demonstrated that protein levels of IFN-c
from lungs of macrophage depleted H1N1-infected mice were
significantly impaired compared to control liposome-treated mice
(Fig. 5H).
Dll1 regulates immune response against influenza
infection
To directly test the effect of Dll1 against influenza infection, we
blocked Dll1 functionality in WT mice by intraperitoneal passive
immunization with anti-murine Dll1 Ab. We confirmed the
specificity of this antibody with stably transfected OP-9 cell lines
for Notch ligands Dll1, Dll4, or Jagged1. The purified antibody
was found to react only with the cell line expressing Dll1 (Fig. 6A).
Mice were treated intraperitoneally with anti-Dll1 or control IgG
antibody (1 mg) on day 0, 2, and 4 of viral challenge. We also
examined the expression of Dll1 from lung macrophages
(CD11b
+F4/80
+) at Day 7 post-infection to demonstrate whether
the Dll1 antibody has an inhibitory effect in vivo. Flow cytometry
analysis showed that the protein level of Dll1 after treating H1N1
infected mice with anti-Dll1 antibody was similar to that seen in
control PBS-treated mice (Fig. 6B). Treatment with this purified
anti-Dll1 Ab led to significantly increased mortality compared to
control IgG treated mice (Fig. 6C). Histological assessment
showed more severe pneumonia in anti-Dll1-treated mice 7 days
post influenza infection (Fig. 6D). Next, viral load was assessed by
measuring both TCID50 (Fig. 6E) and influenza H1N1 viral
specific mRNA for M1 and NS (Fig. 6 F and G). The results
showed significantly higher virus load in the lungs of mice that
received anti-Dll1 Ab compared to controls at day 7 post-infection.
We further demonstrated that the whole lung expression of Hes1,
a downstream transcription factor which is a target of Notch
pathways [17], was significantly lower in the lungs of H1N1
infected mice treated with anti-Dll1 Ab (Fig. 6H).
To help elucidate the mechanism underlying the increased
mortality and severe inflammation seen in anti-Dll1 Ab treated
mice, we examined the cytokine and chemokine profile in whole
lungs during H1N1 challenge. Interestingly, the protein level of
The Role of Dll1 in Influenza Virus Infection
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PLoS Pathogens | www.plospathogens.org 6 November 2011 | Volume 7 | Issue 11 | e1002341IFN-b was significantly higher while that of IFN-c was significantly
lower in H1N1-infected whole lungs from anti-Dll1-treated mice
compared to lungs from control mice 7 days post-infection
(Fig. 7A). Additionally, whole lungs from anti-Dll1 Ab treated
mice at day 7 post-infection had significantly higher protein levels
of CCL2 and CXCL1 (Fig. 7A), molecules that play a critical role
in the recruitment of monocytes/macrophges and neutrophils into
inflammatory lesions. The production of CXCL9 and CXCL10,
which support the migration of Th1 cells, was similar in anti-Dll1-
treated mice and control mice (Fig. 7A). In agreement with the
chemokine and cytokine profile from whole lungs, flow cytometry
demonstrated enhanced macrophage and neutrophil recruitment
during H1N1 infection in anti-Dll1-treated mice at day 7 post-
infection (Fig. 7B). There was no significant difference in the
number of T cells (CD4
+ and CD8
+ cells), NK cells (NK1.1
+),
myeloid DCs (mDCs; CD11b
+CD11c
+), and plasmacytoid DCs
(pDCs; B220
+CD11c
+)( Fig. 7 B and C), whereas the number of
IFN-c
+ cells from each subset (CD4
+, CD8
+, and NK1.1
+) was
significantly lower in anti-Dll1-treated mice (Fig. 7D). Cells
recovered from draining lymph nodes of H1N1-infected mice after
in vitro H1N1 rechallenge, also demonstrated significantly
impaired production of IFN-c compared to control treated mice
(Fig. 7E).
Blocking of Notch signaling abrogates pathogenesis of
influenza virus infection
To directly examine the contribution of Notch signaling during
influenza virus infection, we blocked Notch signaling by using
GSI, a Notch signaling inhibitor. Intranasal administration of GSI
during influenza infection led to higher mortality with excessive
inflammation in the lungs compared to the control DMSO-treated
group (Fig. 8 A and B). Furthermore, viral load assessed by
measuring both TCID50 and influenza H1N1 viral specific mRNA
for M1 and NS indicated significantly higher virus load in the
lungs of mice that received GSI compared to DMSO controls at
day 7 post-infection (Fig. 8 C–E). In addition, the expression of
Hes1 from whole lung was significantly lower in the lungs of H1N1
infected mice treated with GSI (Fig. 8F). We also demonstrated
significantly impaired production of IFN-c from lung CD4
+ and
CD8
+ T cells compared to control treated mice (Fig. 8G).
Moreover, the data illustrate that there were considerable
decreases in IFN-c production of lungs from GSI-treated mice
compared with control DMSO-treated mice (Fig. 8H).
IFN-c production from both CD4
+ and CD8
+ T cells
during the immune response to H1N1 is optimized by
co-culture with lung-derived macrophages
To directly test the effect of Dll1 on the T cells, we performed
an in vitro lung CD4
+ and CD8
+ T cell cytokine expression assay
with H1N1-stimulated lung-derived macrophages from either WT
or IFNaR
2/2 mice with either addition or deletion of Dll1. As
shown in Fig. 9 A and B, lung macrophages from the IFNaR
2/2
mice caused a significant decrease in IFN-c production by T cells
when compared to co-cultures with WT macrophages (white bars).
Moreover, addition of recombinant (r) Dll1 augmented IFN-c
production from T cells isolated from H1N1-challenged lungs and
co-cultured with H1N1-treated lung-derived macrophages. The
levels of IFN-c using macrophages from IFNaR
2/2 or WT mice
were comparable in presence of rDll1. Additionally, anti-Dll1 Ab
significantly decreased IFN-c production from both CD4
+ and
CD8
+ T cells (Fig. 9 C and D). These responses were also seen
when using both CD4
+ and CD8
+ T cells from draining lymph
nodes (Fig. S4).
To verify that the addition of Dll1 to co-cultures of
macrophages and T cells was activating Notch pathways, we used
quantitative real-time PCR to examine Hes1 expression. Cultures
receiving Dll1 showed a 3.6060.45-fold increase in Hes1
expression over cultures with macrophages and T cells alone.
Taken together, our findings suggest that Dll1 is able to skew T
cell maturation via Notch signaling pathways.
Discussion
Our results demonstrate that the Notch signaling pathway and,
in particular, the Notch ligand Dll1 is essential in the regulation of
influenza H1N1 virus infection. To our knowledge, this is the first
report defining this relationship and delineating the underlying
mechanisms. Of the five Notch ligands, Dll1 is the only Notch
ligand specifically upregulated on macrophages following influen-
za stimulation, but it is not expressed on DCs. Also, the peak
expression of Dll1 on lung macrophages in mice coincides with the
period of peak inflammation after H1N1 infection. Our studies
confirmed that lung macrophages from in vivo H1N1 infected
mice expressed Dll1. Blocking Dll1 during viral infection led to
significantly higher mortality and greater accumulation of
inflammatory cells in the respiratory tract. In addition, neutral-
ization of Dll1 during H1N1 infection altered CD4
+ and CD8
+ T
cell activation responses as measured by IFN-c
+ producing cells
within the lung. Together, these results have detailed the
mechanisms by which the elements of the immune system
cooperate and coordinate their efforts to eliminate viral infection.
Our understanding of these mechanisms may possibly lead to
clinical approaches to fight influenza pandemics.
The innate immune response is the first defense of the host to
invading pathogens. Once initiated, proinflammatory cytokines and
chemokines are released which cause macrophages and neutrophils
to migrate to the source of infection [19]. Among the cytokines
induced during the innate immune response, activation of type-I
IFNsisthemostpowerful defensemechanismagainstinfluenzaviral
replication and spread [19]. We first demonstrated that macro-
phages, but not DCs, showed enhanced Notch ligand Dll1
expression in response to influenza virus and to type-I IFN
cytokines, which suggested that Dll1 induction is dependent on
type-I IFNs. We confirmed thisby showing that IFNaR
2/2-derived
BMDMs completely failed to induce Dll1. Influenza virus amplifys
the type-I IFN response via a positive-feedback loop that activates
JAK-1 and Tyk-2 kinases, which leads to the phosphorylation and
Figure 3. RIG-I- and JAK/STAT-dependent Dll1 induction in BMDMs. (A–C) BMDMs were transfected with RIG-I siRNA or control siRNA. The
cells were then incubated with H1N1 for 24 hours (A, B) or for 6 hours (C), and the production of IFN-a (A) and IFN-b (B) was determined by ELISA,
and the expression of Dll1 gene was measured by quantitative real-time PCR (C). **P,0.01 compared with control siRNA treated BMDMs. N.D. = not
detectable (D) BMDMs were stimulated with PolyI:C (10 mg/ml), LPS (1 mg/ml), H1N1 (MOI=10), or rIFN-b (20 Units) for 6 hours, and then expression
of STAT1, phosphorylated (p)STAT1, STAT2, pSTAT2, and Dll1 were measured by western blotting. GAPDH was used as a loading control. (E, F)
BMDMs were stimulated with PolyI:C (10 mg/ml), H1N1 (MOI=10), or rIFN-b (20 Units) for 6 hours, and then Dll1 gene expression was analyzed by
quantitative real-time PCR. (E) Dll1 expression on BMDMs between WT and STAT1
2/2 mice. **P,0.01 compared with WT (129S6) mice. (F) Dll1
expression on BMDMs between DMSO and JAK-I inhibitor treatment (10 mM). **P,0.01 compared with DMSO treatment. Data shown are mean 6
SEM and are a representative experiment of 3 independent experiments. Each point represents at least 4 mice per group.
doi:10.1371/journal.ppat.1002341.g003
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also showed impaired Dll1 induction on BMDMs from STAT1
2/2
mice and BMDMs treated with a JAK-1 inhibitor. PRRs that
recognize influenza virus RNA, have been shown to be a key
initiator of type-I IFN response in infected cells [6]. These PRRs
rely on the RIG-I-like signaling pathway, composed of RIG-I and
MDA5, and also the TLR3-TRIF pathway [5]. Kato et al.
demonstrated that mouse fibroblasts lacking RIG-I, but not
MDA5, are defective in the production of type-I IFN in response
to influenza virus [21]. Our study also showed that RIG-I-knocked
down BMDMs expressed decreased Notch ligand Dll1 with
significantly decreased type-I IFN cytokine production following
influenza virus stimulation. We also observed that MDA5-knocked
down BMDMs expressed levels of Dll1 similar to BMDMs treated
with control siRNA (data not shown). In addition, we showed that
Dll1and type-I IFN production inBMDMswas TRIF independent.
Figure 4. IFNaR
2/2 mice showed higher mortality with impaired Dll1 expression during influenza virus infection. (A) Survival rate in
WT (black), IFNaR
2/2 (red), TRIF
2/2 (green), and MyD88
2/2 (blue) mice. Mice were inoculated intranasally with PBS (dotted line) or H1N1 at 1610
4
PFU (solid line) per each group of mice. Results are expressed as the percentage of survival from 10 individual mice per group. **P,0.01 compared
with WT mice (B) Histological appearance of lungs from WT, IFNaR
2/2, TRIF
2/2, MyD88
2/2 mice at 8 days post-infection of influenza virus (C)
Quantitative real-time PCR was performed to measure the transcript levels of Notch ligands at Day 4 and Day 8 after inoculation of influenza virus.
*P,0.05 compared with WT mice (D) The level of Dll1 in lung macrophages (CD11b
+F4/80
+) from WT or IFNaR
2/2 mice was determined by flow
cytometry at Day 4 and Day 8 after inoculation of influenza virus. *P,0.05, **P,0.01 compared with WT mice. (E) Confocal immunofluorescent
examination of influenza infected lungs at 8 days post-infection, Dll1
+ cells (red) merged with F4/80
+ cells (green) in WT and IFNaR
2/2 mice. Blue
staining indicates DAPI. Original magnification,6200. Shown are representative sections from 1 mouse of 4 per group. Data shown indicate mean 6
SEM and are from a representative experiment of 3 independent experiments. Each time point represents at least 4 mice per group.
doi:10.1371/journal.ppat.1002341.g004
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exclusively RIG-I dependent and that their production is essential
for the induction of Dll1 through the IFNaR and the JAK-1/
STAT1/2 signaling pathway.
Using IFNaR
2/2 mice, our studies confirmed how critical type-
I IFNs are for protection against influenza H1N1 virus in
agreement with a recent report using influenza H5N1 virus [22].
Using a liposome-DMDP system [18], we also demonstrated that
macrophages are indispensable for combating influenza virus
infection. Though the depletion of macrophage seems incomplete
from the number of macrophages remaining, most of the remaining
macrophages in BAL cells from liposome-DMDP-treated mice that
Figure 5. Macrophage is required for protection against influenza virus. Liposome-DMDP or liposome alone (20 ml/dose) was intranasally
administrated to mice on day 1 and day 4 after influenza virus challenge. (A) Survival rate of WT mice treated with either control liposome (black) or
liposome-DMDP (red) after intranasal injection with PBS only (dotted line) or H1N1 (solid line). ***P,0.001 compared with H1N1 group treated with
control liposome. (B–D) Viral load in WT mice treated with either control liposome or liposome-DMDP at 2 and 7 days after infection of influenza virus
(1610
4 PFU). (B) TCID50; Results are shown in log10 scale per lobe. M1 (C) and NS (D) H1N1 viral mRNA. Results are expressed as RNA copies
normalized to GAPDH expression levels, as determined by real-time PCR. *P,0.05 compared with control liposome group. (E) Cellular cytospin
appearance of bronchoalveolar lavage (BAL) harvested from mice treated with either control liposome or liposome-DMDP at day 2 and 7 after
influenza virus infection stained with Giemsa stain. Red arrows show macrophages. Original magnification,61000. (F) The number of cells harvested
from BAL. *P,0.05 compared with control liposome group. (G) Quantitative real-time PCR (Taqman) was performed to measure the transcript levels
of Dll1 at day 2 and 7 after inoculation of influenza virus. *P,0.05 compared with control liposome group. (H) IFN-c production from whole lungs of
WT mice treated with either control liposome or liposome-DMDP at day 2 and 7 after influenza virus infection. Cytokine levels of IFN-c were
measured using a Luminex system. *P,0.05 compared with control liposome group. Data shown indicate mean 6 SEM and are from a representative
experiment of 2 independent experiments. Each time point represents 5 mice per group.
doi:10.1371/journal.ppat.1002341.g005
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production of type-I IFNs from whole lungs during influenza
virus infection was higher in anti-Dll1-treated mice compared
with control Ab-treated mice, suggesting that enhanced type-I
IFNs production from anti-Dll1-treated mice might be due to
impaired viral clearance. These findings indicate that Dll1
expression on macrophages is crucial for protection against
influenza virus.
The initial interaction between invading microorganisms and
the innate immune system critically influences the development of
adaptive antiviral immunity [13]. Although both types of IFNs
(type-I and type-II) play crucial roles in the immediate innate
cellular response to viral infection, the immunomodulatory
activities of IFN-c have a large role in coordinating the adaptive
immune response and in maintaining an antiviral state for longer
times [12]. In addition, there is increasing evidence that the Notch
Figure 6. Passive immunization using Abs against Dll1 abrogates survival rate, lung pathology, and viral load. (A) Western blot
analysis showed the specificity of polyclonal rabbit anti-Dll1 using OP9 cells transfected with various Notch ligands. (B) The level of Dll1 in lung
macrophages (CD11b
+F4/80
+) was determined with flow cytometry using an Ab against Dll1 at day7 post infection; PBS treated mice with either
control Abs (Orange) or Abs directed against Dll1 (Blue), H1N1-infected mice with either control Abs (Red) or Abs directed against Dll1 (Green).
(C) Survival rate of WT mice treated with either control Abs (black) or Abs directed against Dll1 (red) after intranasal injection with PBS only (dotted
line) or H1N1 (solid line). **P,0.01 compared with control Ab group. (D) Histological appearance of lungs isolated from WT mice treated with either
control Abs or Dll1 Abs at day 2 and 7 after influenza virus infection. H&E staining. Original magnification, 640; 6200. (E–G) Viral load in WT mice
treated with control Abs or anti-Dll1 Abs at 2 and 7 days after infection of influenza virus (1610
4 PFU), measured by TCID50 (E) and, M1 (F) and NS (G)
H1N1 viral mRNA. Viral mRNAs are expressed as RNA copies normalized to GAPDH expression levels, as determined by real-time PCR. (H) mRNA
expression of Hes1 in mice treated with control Abs or anti-Dll1 Abs 2 and 7 days after infection of influenza virus. *P,0.05 compared with control Ab
group. Data shown indicate mean 6 SEM and are from a representative experiment of 3 independent experiments. Each time point represents 5 mice
per group.
doi:10.1371/journal.ppat.1002341.g006
The Role of Dll1 in Influenza Virus Infection
PLoS Pathogens | www.plospathogens.org 10 November 2011 | Volume 7 | Issue 11 | e1002341system is an important bridge between APCs and T cell
communication circuits [14,15]. Other studies have demonstrated
that APCs encountering pathogens that skew the immune response
to a CD4
+ Th1 cell response, showed an upregulation of Dll1
[14,23]. Notch signaling is also associated with the differentiation
of naive CD8
+ T to cytotoxic T lymphocytes (CTLs) [24]. We first
demonstrated that depletion of macrophages, a key player in Dll1
induction, induced decreased production of IFN-c from lung
CD4
+ and CD8
+ T cells with dampening of Dll1 levels during
influenza virus infection. The change in Dll1 expression in this
model was minor and suggested that we examined Dll1 expression
in whole lungs. However, the upregulation of Dll1 returns to naı ¨ve
mice levels in the absence of macrophages. Our results further
showed that specifically blocking Dll1 during influenza infection
impaired the survival and inflammatory status in our model with a
decreased number of IFN-c
+CD4
+ and IFN-c
+CD8
+ T cells.
Figure 7. Blockade of Dll1 modulates immune response during influenza virus infection. (A) Protein levels of cytokines and chemokines
in whole lungs isolated from WT mice treated with either control Abs or anti-Dll1 Abs at day 2 and 7 after influenza virus infection using a Luminex or
ELISA system. *P,0.05 compared with control Ab group. (B) FACS analysis of lung macrophage (MØ; CD11b
+F4/80
+), neutrophil (PMN; Gr-1
high),
myeloid DC (mDC; CD11b
+CD11c
+), and plasmacytoid DC (pDC; B220
+CD11c
+) isolated from influenza challenged mice at day 2 and 7. *P,0.05
compared with control Ab group. (C) FACS analysis of lung T cell (CD4
+, CD8
+) and NK cell (NK1.1
+) isolated from influenza challenged mice at day 2
and 7. (D) FACS analysis of intracellular staining of CD4
+ cells, CD8
+ cells, NK1.1
+ cells for IFN-c.* P ,0.05 compared with control Ab group. (E) Whole
cells from the draining lymph nodes of WT mice treated with either control Abs or anti-Dll1 Abs at day 7 after influenza virus infection were
restimulated in vitro with H1N1 for 48 hours. Cytokine level of IFN-c was measured using a Luminex system. *P,0.05 compared with control Ab
group. Data shown indicate mean 6 SEM and are from a representative experiment of 3 independent experiments. Each time point indicates at least
4–5 mice per group.
doi:10.1371/journal.ppat.1002341.g007
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used in clinical trials as a cancer therapy approach, abrogated the
survival and pathogenesis of lung inflammation with a decreased
number of IFN-c
+CD4
+ and IFN-c
+CD8
+ T cells, suggesting the
pivotal role of Dll1 through Notch signaling in driving IFN-c
mediated immune response to influenza virus. The expression of
Hes1 in lungs was upregulated following influenza virus infection,
and the treatment with anti-Dll1 antibody or GSI led to a
decreased expression of Hes1. However, the reduction of IFN-c
from the lungs of influenza-infected mice with these treatments
was approximately 30%. This incomplete reduction might be
attributed to the immunity of NK cells, one of major producer of
IFN-c during influenza virus infection, to these treatments.
APCs, in particular, DCs and macrophages, have a key role in
regulating and modulating the immune response [25]. Our
findings indicated that induction of Dll1 on macrophages in
Figure 8. Blocking of Notch signaling abrogates survival rate, lung pathology, and viral load. GSI (10 nM; 50 ml volume) was intranasally
administrated to mice on day 1 and day 4 after influenza virus challenge. 20% DMSO in 50 ml was used as a control for GSI. (A) Survival rate of WT
mice treated with either control DMSO (black) or GSI (red) after intranasal injection with PBS only (dotted line) or H1N1 (solid line). **P,0.01
compared with H1N1 injection group treated with DMSO (B) Histological appearance of lungs isolated from WT mice treated with either control
DMSO or GSI at day 7 after influenza virus infection stained with H&E. Original magnification,6100. (C–E) Viral load in WT mice treated with DMSO or
GSI at 2 and 7 days after infection of influenza virus (1610
4 PFU) measured by TCID50 (C); Results are shown in log10 scale per lobe. H1N1 viral mRNAs,
M1 (D) and NS (E), were measured. Results are expressed as RNA copies normalized to GAPDH expression levels, as determined by real-time PCR.
**P,0.01 compared with H1N1 injection group treated with DMSO. (F) mRNA exprerssion of Hes1 from whole lungs. (G) FACS analysis of intracellular
staining of CD4
+ cells, CD8
+ cells, NK1.1
+ cells for IFN-c.( H) Cytokine level of IFN-c from whole lungs was measured using a Luminex system. *P,0.05
compared with H1N1 injection group treated with DMSO. Data shown indicate mean 6 SEM and are from a representative experiment of 2
independent experiments. Each time point represents 4–5 mice per group.
doi:10.1371/journal.ppat.1002341.g008
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from CD4
+ and CD8
+ T cells both in vivo and in vitro. Our
studies demonstrate that anti-Dll1-treated mice exhibited signifi-
cantly impaired survival accompanied by an impaired IFN-c level.
Our studies also showed that Dll1 is required for optimal IFN-c
production in response to Ag. Moreover, we demonstrated that
GSI-mediated inhibition of Notch signaling attenuated overall
IFN-c production and resulted in fewer numbers of IFN-c
+CD4
+
and IFN-c
+CD8
+ T cells in our influenza model. Although IL-12
is known to be a strong inducer of CD4
+ Th1 cell development, it
has been reported that the Th1 response induced by Dll-mediated
Notch signaling is IL-12 independent [26]. In our studies, blocking
of IL-12 did not alter IFN-c production from CD4
+ and CD8
+ T
cells in co-culture system of APCs and T cells, and we could not
detect IL-12 production in either BMDM or influenza virus-
infected lungs (data not shown). Thus, our results show that Notch
ligand Dll1 is required to promote IFN-c production from CD4
+
and CD8
+ T cells in IL-12 independent manner, a scenario which
might be important in the protective immune response against
influenza virus.
Several studies support our results showing that IFN-c plays an
important role in recovery from influenza viral infection by
helping to clear the virus [27,28,29]. In contrast, using IFN-c-
deficient mice, Graham et al. showed that IFN-c is not necessary
for recovery from influenza virus infection [30]. Possibly, the
protective or non-protective role of IFN-c is dependent on the
model system. There may be a balance that is perturbed in some
models that inhibits the protective effects of IFN-c during viral
infection. Certainly, given the pleotrophic effects of IFN-c in the
immune response, it is easy to envision that IFN-c KO mice would
experience many different signaling pathway perturbances,
masking the protective effects of IFN-c in a ‘‘normal’’ immune
response to virus infection. Thus, in different models an imbalance
between inhibitory and activating signals could determine the role
of IFN-c after influenza virus infection, with full activation and
signaling through Dll1 overcoming influenza viral-induced-
inhibition of IFN-c. This is also in agreement with the known
protective role for protease-activated receptor-2 against influenza
virus via IFN-c dependent pathway [29]. We have not evaluated
these ideas in our model and further investigations are needed.
Also, lung epithelial cells and fibroblasts play critical roles in
influenza infectious models. However, Dll1 expression was not
upregulated following H1N1 influenza stimulation in lung
epithelial and fibroblast cell lines (data not shown). It is not
known what role the Notch system plays in these cells during
influenza infection; determining this also may reveal a potential
clinical target for fighting influenza virus-induced pneumonia.
Neutrophils and macrophages are the dominant leukocytes
recruited to the lung during an influenza infection [31,32], and
this process is markedly augmented in both IFNaR
2/2 mice (data
not shown) and WT mice treated with anti-Dll1 Ab. The
recruitment of more inflammatory cells into lungs enhances
damage to lung cells and structures, including the respiratory
epithelium, which might be related to higher mortality. Impor-
tantly, we found significantly higher levels of chemokines CXCL1
and CCL2 in infected IFNaR
2/2 mice (data not shown) and WT
mice treated with anti-Dll1 Ab. CXCL1 plays a role in the
recruitment of neutrophils, and CCL2 plays a role in macrophage
recruitment [33]. It has been previously reported that blocking
expression of CXCR2, the receptor for CXCL1, resulted in a
reduction of neutrophil influx with prolonged host survival during
influenza infection [34]. In addition, Dawson et al. showed that
CCR2 deficiency, a major receptor for CCL2, leads to a milder
inflammatory response with reduced lung pathology and increased
survival rates because of defective macrophage recruitment [35].
The above published reports agree with our findings, which show
thathigherCXCL1 and CCL2levelsinboth lungs fromIFNaR
2/2
mice and lungs with anti-Dll1 Ab might be correlated with not only
Figure 9. Activation of IFN-c from lung T cells by lung macrophages during immune responses. (A, B) Lung CD4
+ (A) or CD8
+ (B) T cells
were isolated from influenza virus challenged WT mice and stimulated with H1N1-pulsed lung-derived macrophages from either WT or IFNaR
2/2
mice. Cells were co-cultured with plate-coated rDll1 (2.5 mg/ml) or PBS control. (C, D) Lung CD4
+ (C) or CD8
+ (D) T cells were isolated from influenza
virus challenged WT mice and stimulated with H1N1-pulsed lung-derived macrophages from either WT or IFNaR
2/2 mice. Cells were co-cultured with
control IgG or anti-Dll1 Ab (20 mg/ml). Cytokine level of IFN-c was measured using a Luminex system. Data shown are mean 6 SEM and are from a
representative experiment of 3 independent experiments. Each time point represents 4 mice per group. *P,0.05, ** P,0.01.
doi:10.1371/journal.ppat.1002341.g009
The Role of Dll1 in Influenza Virus Infection
PLoS Pathogens | www.plospathogens.org 13 November 2011 | Volume 7 | Issue 11 | e1002341enhanced neutrophil and macrophage migration into lungs but also
impaired survival rate.
In summary, we present a comprehensive analysis of Notch
ligand Dll1 participation in an infectious model of influenza H1N1
virus. Blockage of Dll1 resulted in accelerated inflammatory
responses and decreased IFN-c levels from CD4
+ and CD8
+ T
cells during influenza infection. Macrophages are indispensable for
the protection against influenza virus by their enhancement of
Dll1 expression levels during infection. Furthermore, Dll1
expression on macrophages was specifically regulated by type-I
IFN. This study supports the concept that an understanding of
Notch signaling, especially Dll1 regulation, in the immune
response to influenza virus can provide mechanistic approaches
that may have clinical applicability.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the University Laboratory Animal
Medicine (ULAM) Facility at the University of Michigan Medical
School. All animal protocols were approved by ULAM and all
efforts were made to minimise suffering.
Mice
WT C57BL/6 mice, WT 129S6 mice, and STAT1
2/2 mice
(129S6 Background) were purchased from Taconic. C57BL/6 mice
lacking the IFNaR gene (IFNaR
2/2) were provided by M. Kaplan
(University of Michigan Medical School). Allmice, including female
MyD88
2/2 and TRIF
2/2 C57 BL/6 mice, were housed in the
University Laboratory Animal Medicine (ULAM) Facility at the
University of Michigan Medical School as described before[36]. All
mice were used for experiments at 8–12 week of age. Age- and sex-
matched mice were used in these studies.
Reagents
Rat mAbs specific for mouse CD3 (17A2), CD4 (L3T4), CD8
(53–6.7), CD11b (M1/70), CD11c (HL3), CD16/32 (2.4G2),
CD45 (30-F11), CD45R/B220 (RA3-6B2), Gr-1 (RB6-8C5),
NK1.1 (PK136), MHC Class II (M5/114.15.2), IL-12 (C17.8),
and IFN-c (XMG1.2) were purchased from BD PharMingen. Rat
Anti-F4/80 (CI: A3-1) mAb was purchased from Serotec. Hamster
anti-Dll1 and anti-Dll4 mAb for flow cytometry were purchased
from BioLegend. Antibodies to STAT1 and STAT2 were
purchased from Cell Signaling Technology, and Millipore,
respectively. PolyI:C was from InvivoGen. LPS from Escherichia
coli (O55:B5) was from Sigma-Aldrich. Mouse cytosine-phosphate-
guanosine (CpG) DNA was from Cell Sciences. Recombinant
mouse IFN-a and IFN-b were from PBL InterferonSource. Mouse
IFN-b Ab for neutralization was from BioLegend. JAK-I inhibitor
and c-secretase inhibitor (GSI) X, a cell-permeable hydroxyethy-
lene dipeptide isostere that acts as a highly specific and a potent
inhibitor of c-secretase were from Calbiochem. DMDP encapsu-
lated liposomes and control plain liposomes were from Encapsula.
Mouse cell lines, RAW264.7, M2-10B4, and LA4 were purchased
from the American Type Culture Collection (ATCC).
Generation of rabbit anti-mouse polyclonal Dll1-specific
antibody
Rabbit anti–mouse Dll1 antibodies were prepared by multiple-
site immunization of New Zealand white rabbits with recombinant
mouse Dll1 (R&D Systems) in CFA and boosted with Dll1 in IFA,
as in previously described procedures from our laboratory [17].
Polyclonal antibodies were titered by direct ELISA against Dll1
coated 96-well plates and titered at 10
7.
Virus infection and sampling
Mice were sensitized by intranasal injection of 1.0610
4 PFU of
influenza A virus strain (strain A/PR8/34; H1N1 isotype: ATCC)
in 30 ml of PBS. PBS was inoculated intranasally into mock-
infected mice. In some experiments, mice were treated intraper-
itoneally with anti-Dll1 or control IgG antibody (1 mg) on day 0,
2, and 4 of viral challenge. Lungs and mediastinal lymph nodes
(LNs) were harvested at the indicated time after influenza
infection. Lung left lobe was used for histological assessment,
and each right lobe was used for the analysis of mRNA, protein,
flow cytometry, and virus infectious titer. Lung homogenates were
serially diluted in Minimum Essential Medium Eagle medium
(Sigma-Aldrich) and virus infectious titers were measured using the
50% tissue culture infectious doses (TCID50) assay based on
cytopathic effect as previously described [31].
Histological and Immunofluorescent examination
Individual excised lung lobes were inflated and fixed with 10%
buffered formalin for morphometric analysis. For immunofluores-
cent analysis, lungs were embedded in Tissue-Tek OCT
compound, and then frozen in liquid nitrogen. Seven-micron
cryostat sections were then fixed in ice-cold acetone, incubated
with primary antibodies, followed by the addition of appropriate
Alexa-labeled secondary reagents (Invitrogen Corp.). Finally, the
sections were analyzed by Zeiss LSM 510 confocal microscope
system (Carl Zeiss Inc.).
Reverse Transcription and Real-time Quantitative PCR
Analysis
Total RNA was isolated from the cultured cells and whole lungs
using RNeasy Mini kit (Qiagen) following the manufacturer’s
instructions and was reverse transcribed in a 25ml volume. Briefly,
1.0 mg RNA was reverse transcribed to yield cDNA in a 25-mL
reaction mixture containing 16 first strand (Life Technologies),
250 ng oligo(dT) primer, 1.6 mmol/L dNTPs (Invitrogen), 5 U
RNase inhibitor (Invitrogen), and 100 U Moloney murine leukemia
virus reverse transcriptase (Invitrogen) at 38uC for 60 min; and the
reaction was stopped by incubating the cDNA at 94uC for 10 min.
The SYBR primer sets for Notch lignads were purchased from
Sigma-Aldrich [16]. Real-time quantitative PCR analysis was
performed using an ABI 7700 sequence detector system (PE
Applied Biosystems). The thermal cycling conditions included 50uC
for 2 min and 95uC for 10 min, followed by 40 cycles of
amplification at 95uC for 15 s and 55uC for 1.5 min for denaturing
and annealing, respectively. Quantification of the genes of interests
were normalized to GAPDH and expressed as fold increases over
the negative control for each treatment at each time point, as
previously described [16]. For virus quantification, cDNA was
synthesized by using MultiScribe reverse transcriptase and random
hexamers (PE Applied Biosystems) as previously described [37]. For
Real-time quantitative PCR, the following SYBR primers were
used: for the M1; forward 5’-CATCCCGTCAGGCCCCCTCA-
3’, reverse 5’-GGGCACGGTGAGCGTGAACA-3’, for the NS;
forward 5’-GGGGCAGCACTCTTGGTCTGG-3’, reverse 5’-
CGCGACGCAGGTACAGAGGC-3’.
Western blotting
BMDMs were lysed in lysis buffer (Cell Signaling), briefly
sonicated, kept on ice for 30 minutes, and centrifuged at 15,000 g
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280uC until use. Equal amounts (15–30 mg) of cell lysates were
fractionated by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (Invitrogen). Then the proteins were transferred
onto a nitrocellulose membrane. After the overnight incubation
with appropriate primary antibody, the membrane was counter-
stained with horseradish peroxidase-conjugated rabbit or mouse
IgG antibody and visualized with enhanced chemiluminescence
detection reagents (GE Healthcare).
Short-interfering (si) RNA assay
A total of 1.5610
6 BMDMs were transfected with 2 mgo fa
mixture of RIG-I (Ddx58)-specific, MDA5 (Ifih1)-specific,
STAT2-specific, or nontargeting control siRNAs (Dharmacon),
using mouse macrophage nucleofector kit (Lonza) according to the
manufacturer’s instructions and plated in a 12-well plate. After
24 hours, cells were used for experiments.
Protein analysis of cytokine
Murine cytokine and chemokine levels were measured in 50 ml
samples using a Bio-plex bead-based cytokine assay purchased
from Bio-Rad Laboratories. IFN-a and IFN-b levels were
measured by ELISA according to manufacturer’s instructions
(PBL InterferonSource). The cytokine levels in lung homogenates
were normalized to the protein present in cell-free preparation of
each sample measured by the Bradford assay, as described
previously [16].
Flow cytometry
Flow cytometric analyses of lung cells were performed as
previously described [16]. In brief, whole lungs were dispersed in
0.2% collagenase (Sigma-Aldrich) in RPMI 1640 (MediaTek) and
5% FBS (Atlas Biologicals) at 37uC for 45 minutes to obtain a
single-cell suspension. The cells were stained with indicated Abs
after 10 minutes of pre-incubation with CD16/CD32 Abs (Fc
block) and fixed overnight with 4% formalin. For intracellular
staining of cytokines, lung cells (1.0610
6 cells/well) were cultured
in 48-well plates containing plate-bound anti-CD3 (5 mg/ml) and
soluble anti-CD28 (2.5 mg/ml). After overnight incubation and in
the presence of GolgiPlug (BD Biosciences — Pharmingen) for the
last 2 hours at 37uC and 5% CO2, the cells were stained for
surface markers with FITC-conjugated anti-CD4, anti-CD8, or
anti-NK1.1 Abs, resuspended in fixation/permeabilization solu-
tion (BD Cytofix/Cytoperm Kit; BD Biosciences Pharmingen),
and stained with PE-conjugated anti–IFN-c Abs respectively. Cells
were analyzed using a Cytomics FC 500 (Beckman Coulter), and
data were analyzed by FlowJo software (Tree Star Inc.).
Generation of BMDCs and BMDMs
BM was harvested from uninfected, normal mice, filtered
through nylon mesh. For generation of BMDMs, BM cells were
cultured in L929 cell-conditioned medium as described previously
[16]. Six days after initial bone marrow culture, BMDM were
transferred to well plates overnight. For generation of BMDCs,
BM cells were seeded in T-150 tissue culture flasks at 10
6 cells/ml
in RPMI 1640-based complete media with GM-CSF 20 ng/ml
(R&D Systems) after depletion of erythrocytes with lysis buffer. 6
days later, loosely adherent cells were collected and incubated with
anti-CD11c coupled to magnetic beads for isolation of conven-
tional DCs from the GM-CSF cultures (Miltenyi Biotec). The
purity of CD11c was more than 94% using flow cytometry. The
cells were plated in well plates overnight. The next day,
macrophages and DCs were infected with certain stimuli.
In vitro T cell treatments
7 days after 1.0610
4 PFU of H1N1 intranasal injection, CD4
+
or CD8
+ T cells from lungs or mediastinal LN were isolated using
a magnetic bead column (Miltenyi Biotec). More than 95% of cells
were CD4 or CD8 positive, respectively. For harvest of naı ¨ve lung
macrophages, the whole lung cells dispersed in 0.2% collagenase
were washed and resuspended in 10-ml RPMI 1640, and then
incubated in a 100-mm cell culture dish for 2 hour at 37uC and
the non-adherent cells were removed. Adherent cells were
collected as lung macrophages, and more than 95% were F4/80
positive. Naı ¨ve lung macrophages were pulsed with H1N1
(MOI=10) for 2 hours, and then T cells (2610
5 cells/well) were
exposed to H1N1-pulsed lung macrophages in 96-well plates at
APC:T cell ratio of 1:5, and supernatants were harvested 48 hours
later for cytokine protein analysis. Plate-bound recombinant Dll1
(rDll1) (R&D Systems) was used at a final concentration of 2.5 mg/
ml, and anti-Dll1 Ab and control IgG were used at a final
concentration of 20 mg/ml.
Statistical analysis
Two-tailed Student’s t test was performed in Prism (Graphpad)
in all cases. of p,0.05 were considered statistically significant.
*P,0.05; ***P 0.01; ***P,0.001.
Supporting Information
Figure S1 Mouse macrophage cell line, RAW 264.7 cells
exhibit increased expression of Dll1. RAW 264.7 cells were
stimulated with PolyI:C (10 mg/ml), LPS (1 mg/ml), CpG (1 mM),
or H1N1 (MOI=10) for 6 hours, then quantitative real-time PCR
was performed and the expression levels of Notch ligands Dll1 (A),
Dll4 (B), Jagged1 (C), and Jagged2 (D) were evaluated. Dll3
expression was below detection levels of our assay.
(TIF)
Figure S2 BMDMs produce type-I IFN following H1N1
as well as PolyI:C and LPS stimulation. BMDMs were
stimulated with PolyI:C (10 mg/ml), LPS (1 mg/ml), CpG (1 mM),
or H1N1 (MOI=10) for 24 hours, then cytokine levels of IFN-a
(A) and IFN-b (B) from supernatants were measured by ELISA
system.
(TIF)
Figure S3 Influenza virus (H1N1) induces increased
gene expression of Dll1 and IFN-b in dose-dependent
manner. BMDMs were stimulated with H1N1 (MOI=0.1, 1.0,
or 10.0) for 6 hours, then quantitative real-time PCR was
performed and the expression levels of Dll1 (A) and IFN-b (B)
were evaluated.
(TIF)
Figure S4 Activation of IFN-c from lung T cells by lung
macrophages during immune responses induced by
influenza virus. (A, B) LN CD4
+(A) or CD8
+(B) T cells were
isolated from influenza virus challenged WT mice and stimulated
with H1N1-pulsed lung-derived macrophages from either WT or
IFNaR
2/2 mice. Cells were co-cultured with recombinant (r) Dll1
(2.5 mg/ml) or PBS control. (C, D) LN CD4
+(C) or CD8
+(D)T
cells were isolated from influenza virus challenged WT mice and
stimulated with H1N1-pulsed lung-derived macrophages from
either WT or IFNaR
2/2 mice. Cells were co-cultured with
control IgG or anti-Dll1 Ab (20 mg/ml). Data shown are
mean6SEM and are from a representative experiment of 2
independent experiments. Each time point represents 4 mice per
group. *P,0.05, ** P,0.01.
(TIF)
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